Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia.
Fedacko J, Pella D, Jarcuska P, Siegfried L, Janicko M, Veselíny E, Pella J, Sabol F, Jarcuska P, Mareková M, Gecková AM, Pazinka P, Jankajová M, Kmec J, Babcák M, Kalanin P, Drazilová S, Babinská I, Cecetková B; HepaMeta Team. Fedacko J, et al. Among authors: babcak m. Cent Eur J Public Health. 2014 Mar;22 Suppl:S69-74. doi: 10.21101/cejph.a3904. Cent Eur J Public Health. 2014. PMID: 24847618 Free article.
Clinical and biochemical determinants of metabolic syndrome among Roma and non-Roma subjects in the eastern part of Slovakia.
Fedacko J, Pella D, Jarcuska P, Siegfried L, Janicko M, Veselíny E, Sabol F, Jarcuska P, Mareková M, Gecková AM, Pazinka P, Jankajová M, Kmec J, Babcák M, Kalanin P, Drazilová S; HepaMeta Team. Fedacko J, et al. Among authors: babcak m. Cent Eur J Public Health. 2014 Mar;22 Suppl:S75-80. doi: 10.21101/cejph.a3905. Cent Eur J Public Health. 2014. PMID: 24847619 Free article.
Effects of Serelaxin in Patients with Acute Heart Failure.
Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators. Metra M, et al. N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291. N Engl J Med. 2019. PMID: 31433919 Free article. Clinical Trial.
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Maggioni AP, Greene SJ, Fonarow GC, Böhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M; ASTRONAUT Investigators and Coordinators. Maggioni AP, et al. Eur Heart J. 2013 Oct;34(40):3117-27. doi: 10.1093/eurheartj/eht342. Epub 2013 Sep 2. Eur Heart J. 2013. PMID: 23999456 Free PMC article. Clinical Trial.
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP; ASTRONAUT Investigators and Coordinators. Gheorghiade M, et al. JAMA. 2013 Mar 20;309(11):1125-35. doi: 10.1001/jama.2013.1954. JAMA. 2013. PMID: 23478743 Clinical Trial.